Nebula Research & Development LLC Crispr Therapeutics Ag Transaction History
Nebula Research & Development LLC
- $836 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding CRSP
# of Institutions
485Shares Held
57.5MCall Options Held
1.09MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$317 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$300 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$120 Million0.01% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$119 Million1.61% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$111 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.12B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....